PTEN somatic mutations are most prevalent in prostate cancer [31], endometrial cancer [32], melanoma [33,34], non-small-cell lung cancer [35,36], kidney [37], breast cancer [38], and glioblastoma [39]. This evidence concerns the gene PTEN and prostate cancer.